Health Committee Republicans Request Details On FDA’s Promotion Of The New Health Care Law

Wednesday, June 19, 2013

All Republican members of the Senate health committee on Wednesday sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Margaret Hamburg requesting details on the agency’s promotion of the new health care law, saying, “The upcoming enrollment period and coverage availability under PPACA appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe."

Senator Lamar Alexander (R-Tn.), the committee’s lead Republican, along with Senators Mike Enzi (R-Wyo.), Richard Burr (R-N.C.), Johnny Isakson (R-Ga.), Rand Paul (R-Ky.), Orrin Hatch (R-Utah), Pat Roberts (R-Kan.), Lisa Murkowski (R-Ak.), Mark Kirk (R-Il.), and Tim Scott (R-S.C.) sent the letter in response to an email alert issued through the FDA’s public email distribution system that promoted open enrollment in the new health insurance exchanges—offering links to a free webinar and promoting the benefits of the law to four different groups: families, individuals, small businesses and clinicians. For example, for clinicians the email detailed “the top five ways you and your practice benefit from the Affordable Care Act.”

The senators wrote: “We are writing to ask why and under what authority the Food and Drug Administration (FDA) is using its time and resources to enroll Americans in health insurance marketplaces created by the new health care law.  On June 3, 2013, the FDA sent a notice to families, individuals, small businesses and clinicians promoting insurance market changes in the new health care law. The e-mail alerts your agency sends to the public should reflect your agency’s actual statutory mission to assure the safety of food, drugs, and medical devices.  The upcoming enrollment period and insurance coverage availability under the new law appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe.”

They added: “In light of the current fiscal environment and recent sequestration, it is especially important to focus scarce resources on FDA’s actual mission. You have said publicly that under the sequester, ‘Clearly we will be able to provide less of the oversight functions and we won't be able to broaden our reach to new facilities either, so inevitably that increases risk.’”

They continued: “While our nation suffers from numerous drug shortages and patients are waiting for drugs and medical device approvals, the FDA should not be using resources designated for these purposes to fund an effort unrelated to your agency’s mission of ‘assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.’ We are also concerned that this is another attempt by the Department of Health and Human Services to avoid congressional limitations on implementation expenditures for the new health care law.”

The full text of the letter is below:

The Honorable Margaret Hamburg

Commissioner

U.S. Food and Drug Administration

10903 New Hampshire Avenue

Silver Spring, MD 20093

Dear Commissioner Hamburg:

We are writing to ask why and under what authority the Food and Drug Administration (FDA) is using its time and resources to enroll Americans in health insurance marketplaces created by the new health care law.  On June 3, 2013, the FDA sent a notice to families, individuals, small businesses and clinicians promoting insurance market changes in the new health care law. The e-mail alerts your agency sends to the public should reflect your agency’s actual statutory mission to assure the safety of food, drugs, and medical devices.  The upcoming enrollment period and insurance coverage availability under the new law appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe.

In light of the current fiscal environment and recent sequestration, it is especially important to focus scarce resources on FDA’s actual mission. You have said publicly that under the sequester, “Clearly we will be able to provide less of the oversight functions and we won't be able to broaden our reach to new facilities either, so inevitably that increases risk."[1]

While our nation suffers from numerous drug shortages and patients are waiting for drugs and medical device approvals, the FDA should not be using resources designated for these purposes to fund an effort unrelated to your agency’s mission of “assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.”   We are also concerned that this is another attempt by the Department of Health and Human Services to avoid congressional limitations on implementation expenditures for the new health care law. 

For these reasons, we would like to know:

1.       Under what legal authority is your agency promoting implementation of the new health care law and/or insurance coverage?

2.       How do your activities further the mission of the Food and Drug Administration?

3.       In addition to the attached email, what additional activities is FDA undertaking to support implementation of the new healthcare law?

4.       What appropriations account is FDA charging for its costs in supporting implementation of the new healthcare law?

5.       What are the total costs to date and what is the amount allocated for the fiscal year for these activities?

Please respond in writing no later than June 26, 2013.

Sincerely,

Lamar Alexander, Ranking Member

Mike Enzi

Richard Burr

Johnny Isakson

Rand Paul

Orrin Hatch

Pat Roberts

Lisa Murkowski

Mark Kirk

Tim Scott

cc:        The Honorable Daniel Levinson, Inspector General

            The Honorable Gene Dodaro, Comptroller General


Aledade Partners With Qsource To Create Primary Care Physician-Led ACO In Tennessee

Maryland-based Aledade, Inc. has announced a partnership with Qsource to help independent primary care physicians in Tennessee form and operate an Accountable Care Organization. Aledade partners with independent doctors to create and run ACOs, networks of physicians who band together to deliver coordinated care to patients.  They operate under a payment structure that rewards ... (click for more)

Department Of Health Southeast Regional Office, Grundy County Health Department Receive Awards

The Tennessee Department of Health Southeast Regional Office and the Grundy County Health Department were honored at the 22nd Annual Excellence in Tennessee Awards Banquet.  The Southeast Regional Office received the TNCPE Level 1 Interest Award which is the beginning level for organizations interested in adopting and applying performance improvement principles.  Grundy ... (click for more)

Robber Is Shot By Victim In Attempted Robbery On East 43rd Street

One person was shot during a robbery attempt at 4314 Rossville Blvd. around 1:50 p.m. on Thursday.  The Chattanooga Police Department is investigating the robbery that ended in a shooting near East 43rd St. at Miller Auto Sales.  The robbery victim shot the suspect.  The suspect was taken to the hospital for treatment of injuries. Chattanooga ... (click for more)

Fire On Crutchfield Street Ruled Arson

Chattanooga fire investigators have determined that last Thursday’s fire at 1207 Crutchfield St.  that nearly killed four people was deliberately set. Lt. Henry McElvain with the Fire Investigation Division said he cannot divulge the reason why he thinks it’s arson, but he is asking for help from the public. If anyone has information that can help solve this case, call ... (click for more)

The Problems With Prescription Drug Addiction

In Tennessee today, we have a major problem with prescription drug addiction, particularly when powerful opioid pain relievers are concerned.    For the first time in 2012, Tennesseans abused prescription opioid drugs more than alcohol.  Our young people ages 18-25 abuse prescription opioids at a 30 percent higher rate than the national average.  In just five ... (click for more)

Roy Exum: The Hillman Of Bihar

In the year of our Lord, 1927, there was a very poor child born to a very poor family in a very poor place. His name was Dasrath Manjhi and he was a native of the Musahar community somewhere in India. We know he had no education and, as a member of the lowest Hindu scheduled castes, he didn’t have a cut dog’s chance from the very get go. But after spending considerable time in ... (click for more)